Genetics

Cambridge Epigenetix (CEGX), a UK-based life sciences company, has announced the recent completion of a $5.5M Series A financing round led by New Science Ventures and the appointment of Dr Fedja Bobanovic as CEO. Joining the financing round were founding investors Syncona Partners and Cambridge Enterprise.

The $3.8 billion the US put into the international effort to sequence the first human genome has delivered $796 billion back to the economy and created 310,000 jobs, says a new study

A national centre for sequencing plant, animal and microbial genomes is to be set up by the UK’s Biotechnology and Biological Sciences Research Council.